Forvis Mazars Wealth Advisors LLC Purchases 1,480 Shares of Procter & Gamble Company (The) $PG

Forvis Mazars Wealth Advisors LLC increased its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 46,258 shares of the company’s stock after purchasing an additional 1,480 shares during the quarter. Forvis Mazars Wealth Advisors LLC’s holdings in Procter & Gamble were worth $7,370,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Sigma Investment Counselors Inc. grew its stake in Procter & Gamble by 2.0% in the second quarter. Sigma Investment Counselors Inc. now owns 33,020 shares of the company’s stock worth $5,261,000 after purchasing an additional 637 shares in the last quarter. Wingate Wealth Advisors Inc. boosted its position in Procter & Gamble by 12.3% during the 2nd quarter. Wingate Wealth Advisors Inc. now owns 2,144 shares of the company’s stock valued at $342,000 after acquiring an additional 234 shares in the last quarter. Planned Solutions Inc. boosted its position in Procter & Gamble by 2.1% during the 2nd quarter. Planned Solutions Inc. now owns 4,142 shares of the company’s stock valued at $660,000 after acquiring an additional 84 shares in the last quarter. Kelman Lazarov Inc. boosted its position in Procter & Gamble by 2.8% during the 2nd quarter. Kelman Lazarov Inc. now owns 5,370 shares of the company’s stock valued at $856,000 after acquiring an additional 145 shares in the last quarter. Finally, Violich Capital Management Inc. boosted its position in Procter & Gamble by 134.8% during the 2nd quarter. Violich Capital Management Inc. now owns 19,642 shares of the company’s stock valued at $3,129,000 after acquiring an additional 11,278 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on PG shares. Barclays dropped their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Wells Fargo & Company dropped their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Berenberg Bank increased their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, BNP Paribas reaffirmed an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $172.21.

Read Our Latest Research Report on PG

Procter & Gamble Stock Performance

Shares of PG opened at $151.53 on Friday. Procter & Gamble Company has a 12 month low of $146.96 and a 12 month high of $180.43. The stock has a fifty day moving average price of $154.92 and a 200-day moving average price of $158.77. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market cap of $354.66 billion, a PE ratio of 23.28, a P/E/G ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the business posted $1.40 EPS. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a $1.0568 dividend. The ex-dividend date is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is 64.98%.

Insider Buying and Selling

In related news, CEO Gary A. Coombe sold 10,194 shares of the firm’s stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 over the last three months. Corporate insiders own 0.20% of the company’s stock.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.